Rhelion Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 10, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	18	11	12	24	45	38
Market Cap Growth	11.73%	-13.65%	-47.83%	-47.03%	16.84%	-64.67%
Enterprise Value	9	2	1	9	26	14
Last Close Price	0.03	0.03	0.03	0.06	0.12	0.10
PS Ratio	4.39	2.54	2.49	4.97	11.29	16.42
PB Ratio	1.64	0.95	0.71	1.17	1.69	1.31
P/TBV Ratio	1.54	0.89	0.71	1.20	1.83	1.41
EV/Sales Ratio	2.25	0.39	0.17	1.94	6.71	5.91
Debt / Equity Ratio	0.13	0.13	0.13	0.09	0.07	0.05
Net Debt / Equity Ratio	-0.73	-0.73	-0.63	-0.66	-0.67	-0.88
Net Debt / EBITDA Ratio	1.99	1.99	3.08	2.48	3.95	2.86
Net Debt / FCF Ratio	3.21	3.21	5.40	3.44	2.73	4.88
Asset Turnover	0.23	0.23	0.22	0.18	0.13	0.07
Inventory Turnover	2.82	2.82	3.23	3.38	3.99	4.16
Quick Ratio	3.05	3.05	3.89	4.88	7.24	9.93
Current Ratio	3.98	3.98	4.53	5.47	8.28	10.15
Return on Equity (ROE)	-47.92%	-47.92%	-22.91%	-33.10%	-20.90%	-46.49%
Return on Assets (ROA)	-15.47%	-15.47%	-11.62%	-14.26%	-9.81%	-17.17%
Return on Capital Employed (ROCE)	-38.70%	-38.70%	-23.40%	-29.50%	-18.00%	-31.50%
Earnings Yield	-33.12%	-57.34%	-32.80%	-32.28%	-12.10%	-37.63%
FCF Yield	-13.90%	-24.07%	-16.34%	-16.60%	-14.46%	-13.84%
Buyback Yield / Dilution	-3.86%	-3.86%	-1.49%	-5.92%	-6.18%	-66.67%